Cannabinoid Education: Needs Assessment Question Title * 1. What type of health care professional are you: Primary Care/ GP/ FP Specialist Nurse / NP Pharmacist Other (please specify) Question Title * 2. What is your specialty: Anatomical pathology Anesthesiology Cardiac surgery Community medicine Dermatology Diagnostic radiology Emergency medicine General pathology General surgery Hematological pathology Internal medicine Medical biochemistry Medical genetics Medical microbiology Neurology Neuropathology Neurosurgery Nuclear medicine Obstetrics and Gynaecology Occupational Medicine Ophthalmology Orthopedic Surgery Otolaryngology Pain Pediatrics Physical medicine & rehabilitation Plastic Surgery Primary care Psychiatry Radiation Oncology Urology Other (please specify) Question Title * 3. How many years have you been providing health care: 0-5 6-10 11-20 20+ Question Title * 4. Please select the Province you practice in: Alberta British Colombia Manitoba New Brunswick Newfoundland Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon Question Title * 5. Please rank your current and desired knowledge/skill level for the following topics: Current knowledge Desired knowledge Understanding of the endocannabinoid system 0 (none) 1 2 3 4 5 (high) Understanding of the endocannabinoid system Current knowledge menu 0 (none) 1 2 3 4 5 (high) Understanding of the endocannabinoid system Desired knowledge menu Understanding of existing cannabinoid medications 0 (none) 1 2 3 4 5 (high) Understanding of existing cannabinoid medications Current knowledge menu 0 (none) 1 2 3 4 5 (high) Understanding of existing cannabinoid medications Desired knowledge menu Prescribing cannabinoids effectively 0 (none) 1 2 3 4 5 (high) Prescribing cannabinoids effectively Current knowledge menu 0 (none) 1 2 3 4 5 (high) Prescribing cannabinoids effectively Desired knowledge menu Understanding of medical marijuana regulations 0 (none) 1 2 3 4 5 (high) Understanding of medical marijuana regulations Current knowledge menu 0 (none) 1 2 3 4 5 (high) Understanding of medical marijuana regulations Desired knowledge menu Awareness of long term risks of cannabinoids 0 (none) 1 2 3 4 5 (high) Awareness of long term risks of cannabinoids Current knowledge menu 0 (none) 1 2 3 4 5 (high) Awareness of long term risks of cannabinoids Desired knowledge menu Question Title * 6. Which cannabinoid(s) have you prescribed: Marinol® (dronabinol) Cesamet® (nabilone) Sativex® (THC:CBD) Medical marijuana None Question Title * 7. For what condition(s) have you prescribed cannabinoids: Nausea and vomiting Anoriexia with weight loss Pain Spasticity Sleep Anxiety Not applicable Other (please specify) Question Title * 8. In your opinion, what are the main limitations of current cannabinoid therapies: (check all that apply) Interactions with other medications Legal issues Limited evidence Mechanism of action Narrow therapeutic window Need for monitoring Not a mainstream therapy Risks Stigma associated with cannabinoids Other (please specify) Question Title * 9. What factors would increase your comfort level with prescribing cannabinoids: (check all that apply) Clinical data and supportive studies Educational programs for physicians Endorsed guidelines/algorithims including cannabinoids Long-term safety data Long-term data evaluating addictive properties New indications Patient education information Peer discussions Other (please specify) Question Title * 10. What are your educational needs for use of cannabinoids in clinical practice: (check all that apply) Screening /Patient Selection Prescribing /Dosing Monitoring Interactions with other medications Costs /Coverage Legal issues /Regulations Other (please specify) Question Title * 11. What format/structure do you prefer for your own learning: (check all that apply) Academic conferences Expert speaker tours Grand rounds Literature reviews Mentorship (preceptorship) program Newsletters Online learning programs Small-group learning sessions Symposia Workshop Other (please specify) Question Title * 12. Additional feedback: Next